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ABSTRACT 
Parasitic infections such as Leishmania induce a cascade of host physiological responses, including 
metabolic and immunological changes. Infection with Leishmania major protozoa causes cutaneous 
leishmaniasis in humans, a neglected tropical disease with suboptimal disease management. To 
understand the determinants of pathology, we studied L. major infection in two mouse models: the self-
healing C57BL/6 strain and the non-healing BALB/c strain. Metabolic profiling of urine, plasma and 
faeces via proton NMR spectroscopy was performed, a method that has shown great promise in 
discovering parasite-specific imprints on global host metabolism. Plasma cytokine status and faecal 
microbiome were also characterised, as additional metrics of the host response to infection. Results 
demonstrated differences in glucose and lipid metabolism, distinctive immunological phenotypes, and 
shifts in microbial composition between the two models. We present a novel approach to integrate such 
metrics using correlation network analyses, whereby self-healing mice demonstrated an orchestrated 
interaction between the biological measures shortly after infection. In contrast, the response observed 
in non-healing mice was delayed and fragmented. Our study suggests that trans-system communication 
across host metabolism, the innate immune system and gut microbiome is key for a successful host 
response to L. major and provides a new concept, potentially translatable to other diseases.  
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INTRODUCTION 
The leishmaniases describe a spectrum of diseases that are caused by protozoan parasites of the genus 
Leishmania. The sum of diseases results in significant health burden globally, estimated at 
approximately 2.4 million DALY’s1, 2. There are severe limitations to the current management of these, 
including variable clinical manifestations and severity of disease (including the cutaneous and visceral 
forms), suboptimal diagnosis, limited treatments and increases in drug resistance.3 A more fundamental 
understanding of the pathogenesis is thus key to progressing novel avenues for more effective 
identification and treatment. 
Experimental research on murine models for cutaneous leishmaniasis (CL) has shown that disease 
outcome depends to a large extent on the immune-phenotype of the host. A dominant Th1 response, 
prevalent in C57BL/6 mice, with marked increased IFNȖ and IL-12 cytokine production, has been 
associated with disease resolution.4, 5 In contrast, a dominant Th2 response with elevated IL-4 levels, as 
observed in BALB/c mice, has been linked with disease progression.6, 7 
Recent evidence has shown that a range of different leukocytes, including different Th subsets, and 
signalling molecules significantly contribute to the host response to Leishmania infection.8-10 
Furthermore, host defence to Leishmania is not solely built on immune components but also relies on 
regulatory metabolic messengers, such as the arginine pathway intermediates.11, 12 This special liaison 
between immune and metabolic system has only found attention in the last few years and hence still 
represents a largely unexplored source of potential new information on infection mechanisms.13-15 
Metabolic profiling has shown great promise in discovering parasite-specific imprints on global host 
metabolism but has not yet been investigated with Leishmania infection in vivo. Such studies on other 
parasitic infections have conventionally relied on 1H nuclear magnetic resonance (NMR) spectroscopy-
based screening of urine and plasma samples, taken from infected rodent hosts for diagnostic 
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biomarker research.16, 17 NMR-based analyses, combined with advances in multivariate statistical tools, 
have shown to yield highly reproducible data, with correlation of variances (CV’s) of major metabolite 
markers typically below 10%.18, 19 This approach in infection studies has expanded successively to 
include tissues and, more recently, to combine metrics from both the metabolic and immune system. 
Such a combined approach enables a more systemic view on host response to a pathogen and 
characterises the immune–metabolic interface during infection.20  
A recurrent theme across a range of these parasite–rodent models characterised by metabolic profiling 
is the association between parasitic infection and an altered host microbiome, as indicated by a set of 
microbiota-associated metabolites detected in the urine and plasma.16, 17, 21 Additionally, results from 
L. major infection models have demonstrated that germ-free mice failed to heal lesions as compared 
with their conventional counterparts, despite generating a strong Th1 immune response22, which 
strongly implicates the microbiota in mounting a successful host response to the parasite. 
The current study was performed to characterise the infection-specific response in a self-healing 
C57BL/6 and a non-healing BALB/c experimental model for CL (Figure 1). We adopted a holistic 
approach to investigate the early phase of L. major infection by combining metrics of the immune, 
metabolic, and gut microbial response in the host, including metabolic profiles from urine, plasma, and 
faeces, selected peripheral cytokines, and faecal bacterial composition. By using this combined set of 
phenotypic metrics, we aim to gain a better understanding of the interactions that lead to the complex 
pathology of leishmaniasis. Moreover, by taking the successfully resistant mouse phenotype as a 
reference system, we intend to define those biological parameters of the host that are associated with 
disease resolution.  
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MATERIALS AND METHODS 
Ethics Statement 
All animal experiments were performed at Imperial College London, adhering to local and national 
animal handling guidelines, under project license PPL70/6997. The protocols were approved by the 
animal ethics committees at London School of Hygiene & Tropical Medicine, Imperial College London 
and the UK Home Office. 
Experimental Model and Sample Collection 
L. major infection was established in 7-8 week old female C57BL/6J mice and BALB/cJ mice (n=15 
per strain, 10 infected and 5 controls), purchased from Charles River Ltd, UK. Mice were fed on 
standard rodent diet (Rat and Mouse No. 1 Maintenance diet, Special Diets Service, UK). Following 
one week acclimatisation, mice were randomly allocated into infection and control groups. Mice in the 
infection group received subcutaneous (s.c.) injections with 2x106 stationary phase L. major 
promastigotes (strain MHOM/SA/85/JISH118, passage 2 ─ culture methods detailed in Supporting 
Information) in 100 μl Schneider’s Insect Medium (Sigma-Aldrich) into the shaven rump, whereas the 
control group received medium only. Plasma, urine, and faecal samples were taken from each mouse 2 
days prior to infection and post-infection at days 2, 6, and at the terminal day of the study, defined as 
the day the lesion had developed in the tail before ulceration occurred (7-13 days post-infection, 
depending on each infected animal), or 12 days post-injection for control animals. Samples were snap 
frozen in liquid nitrogen and stored at -40°C for metabolic analysis. Additional faecal pellets for 
microbial assessment were taken at all four time-points, as well as extra sections of terminal day lesion 
(or skin for controls) for measurement of parasitic burden, which were all fixed in 10% formalin and 
subsequently stored at -20°C. 
1H NMR Acquisition and Processing 
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Plasma, urine and faecal samples were prepared for 1H NMR analyses based on protocols as described 
by Beckonert et al., 200723, where methods for tissue metabolite extraction were adjusted for 
preparation of faeces (Supporting Information). 1H NMR data were acquired on a Bruker Avance 600 
NMR Spectrometer with TXI probe head (Bruker), using XWIN-NMR software (Bruker BioSpin). 
Acquisition settings are outlined in Supporting Information. Spectra were pre-processed using 
automatic phasing, baseline correction and reference peak calibration via an in-house algorithm in 
MATLAB (version R2012b, Mathworks Inc) and Topspin 3.1 software (Bruker BioSpin). Water (and 
urea regions for urine) were removed prior to automatic spectral alignment and probabilistic quotient 
normalisation24, using an in-house MATLAB script.  
Plasma Cytokine Assessment  
Following NMR acquisition, plasma samples were tested in duplicate via the ultra-sensitive plasma 
Th1/Th2 Cytokine 9-plex assay kit (Meso Scale Discovery/MSD) for levels of IFNȖ, IL-1ȕ, IL-2, IL-4, 
IL-5, CXCL1, IL-10, IL-1β and TNFα. Protocols were based on manufacturer’s instructions, with 
sample incubation time increased to 3 hours for increased detection. Assay plates were read on Sector 
Imager 2400 and concentrations calculated using accompanying Discovery Workbench MSD software. 
Faecal Microbiota Diversity Analysis with next-generation sequencing 
Faecal DNA was extracted using QIAmp Stool Mini Kit (QIAGEN) based on manufacturer’s 
instructions with minor protocol amendments (Supporting Information). Presence of microbial genes 
was confirmed via 35 cycles of PCR [30 sec at 95°C, 40 sec at 55°C, 60 sec at 72°C], using primers 
against V1-V3 region of bacterial 16S rRNA genes as described by Lewis et al., 2013.25 DNA samples 
were sequenced via next-generation pyrosequencing using a 454 FLX Genome Sequencer (Roche) by 
Research and Testing Laboratory, LLC (Texas, USA), and data was processed and analysed according 
to company guidelines. In order to be able to discriminate between functionally distinctive groups of 
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bacteria, as opposed to purely genotypic differences when assessing changes at lower taxonomic levels, 
the presented data was analysed at the class level, comparing relative percentage abundance of bacteria 
between samples. Top eight bacterial classes with highest abundance were used for final analyses, 
representing 99.1% of all measured classes across the dataset. 
Parasitic Burden Assessment via real-time PCR 
DNA was extracted from lesion samples using DNeasy® Blood & Tissue Kit (QIAGEN), following 
manufacturer’s instructions, with minor modifications (PBS wash steps before extraction and doubling 
proteinase K for lesion samples). DNA concentration and purity was measured using Nanodrop® 
(Thermo Scientific). Real-time PCR was performed with triplicate samples using SYBR-Green kit 
(Applied BioSystems)26 and primers against mouse arginase 1, to quantify genomic DNA, and 
Leishmania-specific RV1/RV227 to detect parasites. Parasitic burden for each sample was assigned as 
average fluorescent intensity of parasitic DNA as a multiple of the lowest positive reading, normalised 
to arginase levels and calculated with Qbase Plus 2.4 software (Biogazelle). 
Statistical Analysis and Data Integration 
Metabolic spectra of infected and control groups from both strains were initially analysed by Principal 
Component Analysis (PCA).28 Graphical representations of the first several components were used to 
explore overall similarities/differences in metabolic phenotypes, using SIMCA P+ software (V. 12.0, 
Umetrics). Mouse strain differences at the pre-infection time-point, as well as infection-associated 
differences between infected and time-matched control mice for each strain were then explored using 
Orthogonal Partial Lease Squares Discriminatory Analysis (O-PLS-DA)29 which includes a 7-fold 
cross validation for each biological matrix, at each time-point. Final analyses focused on the 
comparison between the infection-related responses of the two mouse models, whereby to account for 
the strain differences, metabolic spectra, cytokine, and microbiome datasets from infected mice were 
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adjusted to their respective control strain by subtracting the uninfected control group median spectra 
level from infected data. The strain-adjusted metabolic data was further analysed via O-PLS-DA. 
Assigned discriminatory metabolites from O-PLS-DA models were selected when the associated 
Pearson-product moment correlation coefficient (r) of a given metabolite peak surpassed the critical 
values for p<0.05 and its ROC sensitivity/specificity score was at least 0.8. Spectral assignments of 
metabolite peaks were performed based on Chenomx NMR suite profiler 7.0 software and using known 
assignments from in-house NMR databases and literature.21 
The differences in individual cytokines and class microbiota levels were analysed using non-
parametric univariate tests: Kruskal-Wallis ANOVA and pair-wise Mann-Whitney U-test for time-
matched strain comparisons, and Friedman tests and Wilcoxon matched-pair tests, for comparative 
analyses between time-points for each mouse model. Bonferroni correction was applied to account for 
multiple testing. Baseline plasma samples from the control groups were lacking thus no control-strain 
adjustment could be performed for plasma metabolic and cytokine data at this time-point, required for 
spectral O-PLS-DA and cytokine univariate analyses, respectively. 
Two-dimensional-matrix, Pearson-based, correlation analyses were performed between time-matched 
spectral data and cytokine levels, spectral data and microbiota class percentages, and cytokine levels 
and microbiota, using in-house MATLAB code (Dr Judith Fonville). The script included a 10,000-fold 
random permutation of sample order. A p-value was calculated as the number of times the absolute 
value of correlation coefficient of the re-sampled data exceeded the original correlation coefficient 
value. Only correlative pairs with p<0.05 were displayed. Twelve metabolites were selected each from 
urine, plasma, and faeces, based on their display of correlations with host cytokines and/or microbiome, 
and on their discriminatory role in differentiating between the two CL mouse models. The integrals 
were calculated and co-analysed alongside time-matched microbiota class percentage abundance and 
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cytokine levels via PCA and PLS-DA, to determine how the different datasets (48 variables in total) 
drive the separation between the two infection models. 
These same variables were correlated via Pearson correlation with relative levels of parasitic burden for 
each mouse model, to determine direct associations between infection and host measures. Furthermore, 
Pearson correlation network graphs were drawn for each time-point in both strains individually, to 
determine specific host interactions between variables, in response to infection, using in-house 
MATLAB code based on MetaboNetworks software.30 A generous cut-off for the q-values of 0.3 using 
the Storey-Tibshirani False Discovery Rate31 was applied for multiple testing correction in the 
parasite–host correlation as well as correlation network analyses, for maximal exploration of potential 
biologically relevant host interactions in this study. The sample size of this study was small and future 
studies are needed to perform targeted analyses to test these associations. The majority of associations 
are still expected to be true discoveries. 
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RESULTS 
BALB/c and C57BL/6 mice have different metabolic, immune, and gut microbial phenotypes in 
response to L. major infection 
Among the physiological and pathological measures that were monitored between the two strains 
within the first two weeks of infection, only the haematocrit differed significantly (Table S1). No 
significant changes were observed in weight, day of lesion onset, or lesion size (though trends showed 
that the BALB/c had larger overall lesions). Infection with L. major was confirmed via real-time PCR 
of L. major DNA in lesions taken at the terminal time-point (days 7-13 post infection, the most acute 
phase of the infection in our study), with no significant differences observed between strains. 
In contrast to the minor pathological changes, the strains displayed clear strain and infection-related 
differences in their metabolism across the three assessed biofluids: urine, plasma, and faecal extracts. 
Preliminary multivariate analyses using PCA and O-PLS-DA revealed that strain differences prior to 
infection included significantly higher levels of glucose and lactate with lower lipid moieties, in plasma 
of C57BL/6 mice compared with BALB/c. The latter strain also displayed relatively higher lipid levels 
in their faeces, along with lower amounts of urinary citrate, succinate and 2-oxoadipate. Infection 
resulted in significant decreases in plasma glucose and urinary hippurate across both strains, as well as 
decreases in plasma lipids in non-healing BALB/c mice. To investigate the differences in metabolic 
infection-related responses between the two models, finalised results (Table S2) were based on O-PLS-
DA on spectra that took into account strain differences unrelated to infection by adjusting each infected 
group to their respective uninfected control strain, a method that was also applied to subsequent 
cytokine and microbiome data (Materials and Methods). Metabolites with significantly higher levels in 
the non-healing strain for at least one post-infection time-point included alanine (in plasma and faeces), 
succinate (faeces), 3-hydroxybutyrate (3-HB) and glucose (in plasma), as well as the gut-microbiota-
associated metabolites phenylacetylglcyine (PAG) and trimethylamine (TMA) in the urine. In contrast, 
12 
 
metabolites found in higher concentrations in the self-healing strain after infection included urinary 
acetate and several fatty acid moieties from lipoproteins in plasma.  
Out of the nine cytokines initially tested in plasma, four displayed detectable levels, namely IL-1ȕ, 
IL-10, IL-12 and CXCL1. IL-1ȕ was the only cytokine to be significantly different between the two 
strains prior to infection (higher in BABL/c mice, p=0.006). Following strain adjustment, infection-
related differences between the models (Figure S1) showed that non-healing mice generally had higher 
levels of the pro-inflammatory cytokines CXCL1 and IL-1ȕ than the self-healing model over all time-
points, though reaching statistical significance only for IL-1ȕ, 6 days post-infection (d 6 p.i., p=0.036). 
They also had higher levels of cytokine IL-12 than self-healing mice, 2 days post infection (d 2 p.i., 
p=0.013). 
To compare faecal microbial composition between animals, we assessed changes in percentage 
abundance of bacterial classes (further outlined in Materials and Methods). Clostridia (phylum 
Firmicutes) and Gammaproteobacteria (phylum Proteobacteria) were the most dominant classes of 
faecal bacteria observed in this study across both strains, accounting for over 85% relative abundance 
of the total data. Initial trends showed that Clostridia were higher in BALB/c mice whilst 
Gammaproteobacteria were higher in C57BL/6 mice before infection, yet this was not significant. 
Following strain-adjustment, infection-related microbial levels for Clostridia remained consistently 
higher in the BALB/c strain, reaching significance at the terminal time-point (p=0.003, Figure 2A). A 
considerable decrease in relative Gammaproteobacteria levels was observed in both strains by the end 
of the study (significant in C57BL/6 mice, p=0.048), although levels in C57BL/6 mice remained 
significantly higher than in BALB/c mice (p=0.006, Figure 2B). 
Erysipelotrichia represented the third most abundant bacterial class, which was largely absent in 
BALB/c mice and, where present, was significantly lower than in self-healing C57BL/6 mice, d 6 p.i. 
(p=0.013; Figure 2C, Table S3). The remaining bacterial classes were only detected at low levels 
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(typically less than 5% relative abundance), although significant changes relative to baseline were 
detected in self-healing mice, e.g. increases in Alphaproteobacteria (d 2 p.i., p=0.048) and Bacteroidia 
(d 2 p.i., p=0.012 and terminal, p=0.048) and decreases in Actinobacteria (d 6 p.i., p=0.027) and Bacilli 
(terminal day, p=0.048; Table S4). No significant changes in faecal bacterial composition were evident 
over the study period in non-healing mice, indicating a more static microbial population than that 
observed in the self-healing model (Tables S3 and S4). 
 
Peripheral cytokines correlate with the systemic host metabolism 
Correlation analysis was performed between cytokine and NMR spectral data, in order to identify 
associations between the host immune and metabolic system in response to infection, for each of the 
murine phenotypes. Results showed that multiple interactions existed between the cytokine and the 
metabolite data for all three biofluids (Table 1), with a higher number of correlations determined in the 
self-healing strain. Certain immune-metabolic correlates were common to both the self-healing and 
non-healing models, e.g. a negative association between urinary hippurate and IL-10. Other 
correlations were specific to a particular CL model: urinary ureidopropanoate, for instance, was found 
to be negatively correlated with IL-12, IL-1ȕ and CXCL1 in the non-healing strain but did not correlate 
with cytokines in the self-healing model. In several instances, particularly in non-healing mice, 
metabolites that were correlated with IL-12, IL-1ȕ and or CXCL1 produced opposing or no correlative 
associations with regulatory cytokine IL-10. These disparate correlation patterns included 2-
oxoisocaproate, PAG and lactate in the urine. 
 
Clostridia and Gammaproteobacteria display opposing associations with host metabolites 
Extending further from the immune-metabolic correlations, associations between the host faecal 
microbiome and metabolism were similarly investigated, using percentage abundance of the different 
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bacterial classes and spectral NMR data as input parameters. Results for plasma and faeces have been 
summarised in Table 2 (Table S5 for urine). The majority of the metabolites that were negatively 
linked with the Clostridia class were positively linked to Gammaproteobacteria and vice versa in both 
mouse models. Such correlative metabolites included choline, glycerophosphocholine (GPC), plasma 
lipids, lactate, the gut-microbiota associated molecules hippurate, PAG and TMA, and metabolites 
related to the tricarboxylic acid cycle (e.g. acetate and fumarate) in the urine. Erysipelotrichia 
displayed similar correlation patterns with host urinary and faecal metabolites as Clostridia in both CL 
models, as well as with plasma metabolites in the self-healing C57BL/6 strain. 
 
Multiple links between cytokines and faecal microbial classes in both infection models 
Details of the correlation analyses between cytokine concentrations and microbial class abundances 
are summarised in Table 3. IL-1ȕ displayed the highest number of correlations with the microbiota in 
the self-healing phenotype. IL-1ȕ was found to be positively correlated with all microbial classes for at 
least one time-point in self-healing mice, yet was only correlated with Bacilli and 
Gammaproteobacteria in non-healing mice. IL-12 and IL-10 displayed the most immune-microbial 
correlations out of all the cytokines in the non-healing mice. Actinobacteria and Bacteroidia classes 
were strongly positively correlated with IL-10 levels in both strains, suggesting these commensal 
bacteria may exert IL-10 dependent anti-inflammatory effects on the host. 
 
Differences in metabolic and microbial responses to L. major infection dominate separation 
between the self-healing and the non-healing phenotype 
To ascertain the relative contribution of the host metabolic, immunological, and microbial 
backgrounds towards differentiating the two mouse strains’ responses to L. major infection, metabolite 
integrals, cytokine concentrations, and bacterial percentage abundances were co-analysed by Partial 
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Least Squares discriminatory analyses (PLS-DA), shown in Figure 3. Average correlation of variances 
(CV’s) for the selected metabolites across all post-infection time-points were 27.7% (urine), 39.2% 
(plasma) and 16.4% for BALB/C mice, and 32.8% (urine), 35.3% (plasma) and 20.5% for C57BL/6 
mice. Analyses showed that metabolites in the urine and plasma represented the major drivers of 
separation between host responses of the two strains to infection, particularly at the beginning of 
infection, e.g. urinary hippurate and plasma glycine were found in higher concentrations in the self-
healing phenotype (Figure 3). Hippurate remained consistently higher in this strain throughout the 
study, in addition to urinary creatine, faecal glutamate, and levels of the Erysipelotrichia and 
Betaproteobacteria. In contrast CXCL1, urinary PAG and plasma levels of 3-HB and lipid methyl 
groups were consistently higher in non-healing mice throughout infection. With infection progression, 
the faecal microbiota became the most discriminatory variables between the two strains. By the 
terminal time-point, members of the Gammaproteobacteria class were strongly linked with self-healing 
mice whilst Clostridia and Bacilli classes were associated with the non-healing phenotype (Figure 3). 
 
Parasitic load associated with a select set of metabolic, immunological and microbial markers 
In order to assess whether parasitic burden was linked to host metabolism, immune status and/or 
faecal microbiota, relative fluorescent intensities of lesion-derived L. major DNA were correlated with 
the same variables as used for the previous PLS-DA models (Figure 4). Faecal succinate and IL-12 
were found to be positively linked with parasitic load in the self-healing mouse strain. In contrast, 
plasma scyllo-inositol, faecal acetate and Betaproteobacteria were positively associated with parasite 
ounts in non-healing mice, whereas urinary 2-oxoisocaproate was negatively correlated. 
 
L. major results in a CL model-specific systems response between host metabolism, immune 
system and microbiota 
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Pair-wise Pearson correlation analysis was performed between selected variables to assess potential 
associations between the different host responses within each infection model. A separate model was 
built for each time-point and plotted as correlation network wheels, shown in Figure 5. The level of 
inter-connectivity between the variables differed between the two strains, even prior to infection, where 
the non-healing strain displayed hardly any correlations between variables (Figure S2). Infection 
resulted in a substantial increase in the number of correlative associations in the self-healing strain at d 
2 p.i., the highest observed in this study, whereby each variable was directly correlated with at least one 
other variable. At d 6 p.i., non-healing mice displayed more associations between variables than earlier 
time-points, whilst correlations between variables in self-healing mice became more confined to their 
individual biological matrices. Multiple correlations were still observed in both models at the terminal 
time-point, whereby the two strains displayed many similarities in their correlation patterns. 
Whilst the constrained format of the correlation wheels allows for direct comparisons of variables 
between strains or time-points, results were additionally depicted as network maps (Figures 6 and S3). 
The topology of the network maps is more conducive to interpretation than the correlation wheels, 
favouring the visualization of major hubs and chains of correlation within the networks, and thus more 
aligned with mapping to biological pathways. The maps demonstrated that metabolites in plasma and 
urine represented the core frameworks within the networks during the course of infection in both 
models, displaying the highest number of inter- and intra-matrix correlations. Acetate, citrate, and 
alanine represented major network hubs in the self-healing mouse model, with some of the highest 
numbers of direct associations across all three post-infection time-points. Unlike C57BL/6, network 
hubs in the non-healing strain were less stable through time and alternated throughout the course of the 
study, with only plasma lactate remaining highly correlated with other variables at the three post-
infection time-points. 
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With the exception of d 2 p.i. in the BALB/c mice, IL-10 was consistently connected with multiple 
host components within the core network of both phenotypes, highlighting its systemic regulatory role 
within the host. The pro-inflammatory cytokine CXCL1 was directly correlated with numerous 
bacterial classes and metabolites across different biological matrices in both infected strains. IL-12 
produced negligible correlations in the self-healing strain in the current study. Within the microbiota 
data, Bacilli and Bacteroidia classes were consistently disconnected from the core network hubs and 
were connected largely with themselves, if correlated at all. Clostridia and Gammaproteobacteria were 
negatively correlated with each other in both models across multiple time-points.  
18 
 
DISCUSSION 
The current study presents a systematic characterisation of the global metabolic profile, peripheral 
cytokine status, and the faecal microbiome in both susceptible BALB/c and self-healing C57BL/6 
mouse models of CL. The specific objective of the work was to reveal the immune–metabolic–
microbial phenotype that underlies a successful response to L. major, using an integrated network 
approach. Within the immunological context of this study, the first assessed post-infection time-point 
(d 2 p.i.) represents an immune response that is entirely driven by innate factors. The two later time-
points assessed (d 6 p.i. and terminal) are generally thought to be driven by the host’s adaptive 
immunity.32 Whilst our study focused only on the early stages of disease, trends in increased lesion size 
and parasitic burden were already apparent in the non-healing model. 
Key differences in strain-related metabolic responses towards infection included changes in glucose 
and lipid metabolism. The non-healing BALB/c mice appeared to rely predominantly on fatty acids 
rather than glucose as source of energy during infection, reflected by the relative increases in plasma 
glucose and 3-HB: a ketone body generated from fatty acid breakdown.33 Biochemical blood results 
from the supplier indicate that BALB/c mice typically have nearly twice as much circulating 
triglycerides and lower levels of glucose in their blood than C57BL/6 mice.34, 35 This finding was in 
line with our results, where baseline plasma lipid moieties were also higher in BALB/c mice than in the 
C57BL/6 strain. However, L. major infection induced a pronounced decrease in lipids BALB/c mice 
only. It may thus be speculated that due to their high bioavailability, metabolism of fatty acids 
represents a major alternative for energy production in BALB/c mice not only in general but also more 
importantly in response to infection. 
Alanine and succinate concentrations were found to be consistently higher across multiple biofluids (in 
faeces and for alanine, also in plasma) in the non-healing phenotype throughout infection. Both 
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metabolites represent major waste products of Leishmania species36 and our results showed that 
succinate was also directly correlated with parasitic burden. Earlier in vitro studies have shown 
concentrations of alanine and succinate to be significantly higher in cell media from L. major infected 
macrophages when compared to uninfected macrophages37, highlighting their potential role as 
biomarkers of Leishmania infection. It is thus plausible that these metabolites may in fact be directly 
derived from the parasite. Urinary hippurate levels decreased upon infection in both strains and, upon 
control-strain adjustment, were consistently found to be lower in the non-healing infected BALB/C 
mice when  compared to the self-healing strain. Interestingly, a decrease in hippurate has also been 
observed in previous experimental rodent parasitic models (e.g. in Trypanosoma brucei brucei and 
Schistosoma. mansoni infections), indicating that this may be a more general marker of parasitic 
infection.16, 17 
Immunological investigation of the two infected strains confirmed the importance of the innate immune 
system driving the differential response during early stages of infection, whereby the non-healing 
model displayed an inherent pro-inflammatory phenotype compared with the self-healing strain. In 
contrast to published evidence38, defining the role of Th1 cytokine IL-12 in the current study proved 
difficult, not only owing to the variable concentrations measured over the course of infection in both 
strains, but due to its observed positive association with parasitic load. 
Following infection, marked changes in faecal bacterial composition were observed, most notably, the 
expression levels of members of the Clostridia class, which were higher in the non-healing strain, and 
Gammaproteobacteria classes, that were higher in self-healing mice. Our results indicate that the 
abundance of Clostridia and Gammaproteobacteria were inversely correlated, a finding that was also 
reported following weight-loss through bariatric surgery in rats by Li and colleagues.39 In our study, the 
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two bacterial classes are often linked with the same metabolite but demonstrate contrasting 
directionality, a phenomenon that was apparent in both strains of mice. 
Parasitic counts within the lesion of infected mice produced significant correlations with select 
biomarkers across the different responses assessed in this study. Twice as many correlates were 
observed in the non-healing mice. Plasma scyllo-inositol, an organic osmolyte that has recently been 
found to be associated brain disorders40, represented the strongest associated variable with parasite 
counts in this strain. 
Correlation network analyses between the host metabolic, cytokine, and faecal microbial responses 
during infection uniquely demonstrated direct statistical interactions between host components. 
Remarkable differences in the level of inter- and intra-matrix correlations were observed between the 
two strains and sampling time-points. The self-healing C57BL/6 strain displayed the maximal number 
of correlations between cytokines, microbiota, and metabolites 2 days after infection. Acetate, citrate 
and alanine represented major network hubs in the self-healing strain, implying that these metabolites 
may prove significant in orchestrating a systemic response towards Leishmania. 
Acetate represents a key metabolite central to the metabolism of both carbohydrates and fatty acids, 
used predominantly for the formation of acetyl coenzyme A. Additionally, it is the main short-chain 
fatty acid readily reabsorbed from the colon back into systemic circulation and thus also acts as a 
marker of colonic fermentation of dietary carbohydrate.41 Both citrate (a tricarboxylic acid 
intermediate) and alanine (a gluconeogenic amino acid via the Cahill pathway42) represent markers 
linked with host energy metabolism. Thus results from our study emphasise the focal role of 
carbohydrate metabolism within the self-healing model during infection, presumably to account for the 
high energy requirements to mount a successful system response towards the pathogen. In the non-
healing mice, the highest number of associations between variables was observed 6 days post-infection, 
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with few correlations observed at earlier time-points. The associations in the non-healing phenotype 
appeared to be connected at random (disordered) rather than as functionally structured hubs, as in self-
healing mice. It could thus be hypothesised that these highly connected interactions between multiple 
compartments within the host are vital for mounting a rapid and effective innate immune response 
towards L. major, as seen in the self-healing state. 
 
CONCLUSIONS 
In summary, our systemic approach to the characterisation of two experimental models of a L. major 
infection adds a novel aspect to the assessment of host defence, which can be applied to other disease 
models. Tangible differences between the infection models included differences in energy metabolism, 
inflammatory status, and gut microbial composition. Furthermore, our study revealed parasitic-linked 
metabolites that were higher in the non-healing model and provide novel candidates to be further 
investigated as potential biomarkers of Leishmania infection. Globally we have shown that already 
during the innate immune response, an efficiently orchestrated network of metabolic, immunological, 
and gut microbial features may be linked to a successful pathogen defence. Infection in the self-healing 
model displayed a comprehensive correlation network between multiple biological responses towards 
the parasite that was not present in the non-healing model, which may explain the superiority of this 
strain in controlling disease. We have also identified a suite of metabolic candidates that represented 
major network hubs linked to a successful immune response to L. major, which can be further explored 
to ascertain potential indices for immune-modulatory and/or leishmanicidal activity. 
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FIGURES 
 
 
Figure 1. Schematic overview of study 
Study compares experimental cutaneous leishmaniasis in non-healing BALB/c mice versus self-healing 
C57BL/6 mice, during early phases of L. major infection (see Materials and Methods). *Terminal day 
defined for each infected mouse on the day shortly before lesion ulceration (days 7-13) or on day 12 for 
control mice. 
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Figure 2. Changes in faecal microbial composition between the two mouse CL models 
Infection-related changes in composition of the bacterial classes Clostridia (A), Gammaproteobacteria 
(B) and Erysipelotrichia (C) in faeces of infected mice, adjusted to their respective control strain. 
Horizontal bars represent group median averages and each symbol represents a faecal sample (n=10 for 
all groups except C57BL/6 Day 6 where n=9).  
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Figure 3. Discriminatory variables between two infection models for each post-infection time-point 
assessed via PLS-DA 
Scores plots (A) and corresponding loadings plots (B) of Partial Least Squares discriminatory analyses 
(PLS-DA) between the two infected strains are presented, based on the first component vector for 2 
days and 6 days post-infection and at the terminal study day. A) Each circle represents one sample. 
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BALB/c (blue) and C57BL/6 (green) samples are separated into the two infection models, vertically 
along the first PLS vector t[1]. Horizontal hashed lines represented two and three standard deviations 
(SD) from the mean. B) Relative contribution of each of the discriminatory variables (circles) towards 
the vertical mouse model separation in the associated scores plot, composed of 48 markers in the 
following order: 12 urinary (u), 12 plasma (p), and 12 faecal metabolites (f), four cytokines, and eight 
percentage abundance of eight microbial classes. Origin of metabolites present in more than biofluid 
additionally labelled with (u), (p) or (f). R2 and Q2 describe fit and predictive value of each model, 
respectively. Key: 3HB, 3-hydroxybutyrate; GPC, glycerophosphocholine; PAG, pheynylacetylglycine; 
TMA, trimethylamine; TMAO, trimethylamine-N-oxide; UK 3.65m, unassigned multiplet at δ γ.65. 
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Figure 4. Correlation between parasitic burden and host response markers in non-healing and self-
healing CL models 
Plot shows Pearson correlation between relative amount of L. major DNA in lesions (Table S1) from 
infected BALB/c and C57BL/6 mice, and levels of infection-related metabolic, immune and faecal 
microbial variables (terminal time-point). Each variable is represented by a small circle, where 
significantly positively correlated variables are boxed in red and negative in blue (q<0.3). Key: faecal 
metabolites; 1, unassigned multiplet peak at δ 3.65; 2, tyramine; 3, trimethylamine (TMA); 4, 
dimethylamine; 5, glutamate; 6, taurine; 7, succinate; 8, lipid (CH3); 9, lactate; 10, propionate; 11, 
butyrate; 12, acetate. Plasma metabolites; 13, citrate; 14, glycine; 15, creatine; 16, alanine; 17, scyllo-
inositol; 18, glycerophophocholine; 19, choline; 20, 3-hydroxybutyrate; 21, lipid (CH2); 22, lipid 
(CH3); 23, glucose; 24, lactate. Urine metabolites; 25, ureidopropanoate; 26, citrate; 27, acetate; 28, 2-
oxoisocaproate; 29, creatinine; 30, creatine; 31, lactate; 32, trimethylamine-N-oxide; 33, TMA; 34, 
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phenylacetylglycine; 35, hippurate; 36, taurine. Bacterial classes; 37, Clostridia; 38, 
Gammaproteobacteria; 39, Erysipelotrichia; 40, Alphaproteobacteria; 41, Betaproteobacteria; 42, 
Bacilli; 43, Actinobacteria; 44, Bacteroidia. Cytokines; 45, CXCL1; 46, IL-1ß; 47, IL-12; 48, IL-10. 
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Figure 5. Correlation wheels of metabolic, immune, and microbial markers during acute infection in 
two CL models 
Correlation networks for each measured time-point post-infection based on pair-wise Pearson 
correlation between selected variables for L. major infected BALB/c and C57BL/6 mice (see Figure S3 
for pre-infection results). Red and blue connecting lines between variables represent significant 
positive and negative correlations, respectively (q<0.3). The structure of the wheels is constrained such 
that variables have a fixed position and have colour-coded nodes along the circumference. Key: Grey, 
faecal metabolites; 1, unassigned multiplet peak at 3.65 ppm; 2, tyramine; 3, trimethylamine (TMA); 4, 
dimethylamine; 5, glutamate; 6, taurine; 7, succinate; 8, lipid (CH3); 9, lactate; 10, propionate; 11, 
butyrate; 12, acetate. Red, plasma metabolites; 13, citrate; 14, glycine; 15, creatine; 16, alanine; 17, 
scyllo-inositol; 18, glycerophophocholine; 19, choline; 20, 3-hydroxybutyrate; 21, lipid (CH2); 22, 
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lipid (CH3); 23, glucose; 24, lactate. Yellow, urine metabolites; 25, ureidopropanoate; 26, citrate; 27, 
acetate; 28, 2-oxoisocaproate; 29, creatinine; 30, creatine; 31, lactate; 32, trimethylamine-N-oxide; 33, 
TMA; 34, phenylacetylglycine; 35, hippurate; 36, taurine. Cyan, bacterial classes; 37, Clostridia; 38, 
Gammaproteobacteria; 39, Erysipelotrichia; 40, Alphaproteobacteria; 41, Betaproteobacteria; 42, 
Bacilli; 43, Actinobacteria; 44, Bacteroidia. Dark blue, cytokines; 45, CXCL1; 46, IL-1ß; 47, IL-12; 
48, IL-10. 
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Figure 6. Correlation network map of metabolic, immunologic and microbial markers in response to 
early infection in two mouse CL models 
Correlation networks based on pair-wise Pearson correlation between all variables for BALB/c and 
C57BL/6 mice infected with L. major, at 2 and 6 days post-infection (see Figure S3 for terminal). Red 
and blue connecting lines between variables represent significant positive or negative correlations, 
respectively (q<0.3). Variables are grouped according to correlation clusters and are colour coded in 
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boxes according to their compartments: urine in yellow, plasma in red, cytokines in dark blue and 
bacterial classes in cyan. Key: 3HB, 3-hydroxybutyrate; DMA, dimethylamine; GPC, 
glycerophosphocholine; PAG, phenylacetylglycine; TMA, trimethylamine; TMAO, trimethylamine-N-
oxide; UK 3.65m, unassigned multiplet peak at δ 3.65.  
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TABLES 
Table 1. Immune–metabolic correlates in urine, plasma, and faeces of the self-healing and non-healing 
CL infection models 
 
Biofluid Metabolite 
Correlate 
Infected BALB/c Infected C57BL/6 
IL-10 IL-12 IL-1ȕ CXCL1 IL-10 IL-12 IL-1ȕ CXCL1 
Urine 
2-oxoadipate*     -  -  
2-oxoglutarate       -  
2-oxoisocaporate + - - -  +   
Acetate    - -    
cis-Aconitate   -      
Citrate  -    +  + 
Creatine    - +/-   + 
Creatinine   -      
Fumarate    -     
Guanidoacetate  -  +     
Hippurate - -   -    
Lactate + - -  -  -  
PAG  +  +/-  + + + 
Succinate    -   -  
Taurine - -  +/- +/- - + + 
TMA       - - 
TMAO     + +  +/- 
Ureidopropanoate  - - -     
Plasma 
3-HB        + 
Choline  +       
Glucose + +  - +/-  + +/- 
Glycine     -    
GPC  -       
Lactate +/- - -    +  
Lipid CH2  -   +   + 
Lipid CH3  -   +   + 
Lipid* 3.22(m)     +   + 
scyllo-Inositol*   -      
Faeces 
Butyrate  -  - +    
Glutamate      -   
Lactate      +  +/- 
Lipid CH3      +   
Propionate  +    +  + 
Succinate       - + 
Taurine      +   
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Key: +, positive correlations; -, negative correlations; +/-, direction of correlation alternated between 
different time-points; *, tentative assignment; 3-HB, 3-hydroxybutyrate; GPC, glycerophoshocholine; 
(m), unassigned multiplet (accompanied by chemical shift region); PAG, phenylacetylglycine; TMA, 
trimethylamine; TMAO; trimethylamine-N-oxide. 
 
Table 2. Microbial–metabolic correlates in plasma and faeces in the self-healing and non-healing 
infection models 
Biofluid 
Metabolic 
Correlate 
Clos Gamma Erysi Alpha Beta Bacil Actino Bacter 
BALB/c: 
Plasma 
3-HB   + +   +  
Choline + - + +   + + 
Glucose -  + - - - + - + 
GPC - + + - -   - 
Lactate    +/-  - -  
Lipid* 3.22(m)   + -   +  
Lipid CH2  + + +/- -  +  
Lipid CH3   + +/- -  +  
s-Inositol*    - +/-  + - 
BALB/c: 
Faeces 
Acetate   -      
Butyrate - + -  + +  - 
Lactate      -   
Propionate  + -   -   
Succinate      -   
C57BL/6: 
Plasma 
3-HB - + - -     
Choline - +       
Glucose   - -   - - + + 
GPC - +       
Lactate -      -  
Lipid* 3.22(m) - + -      
Lipid CH2 - + -      
Lipid CH3 -  -      
C57BL/6: 
Acetate     + + -  
Butyrate       -  
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Faeces DMA   -      
Glutamate   -   -   
Lactate - + - -    + 
Propionate - +     -  
Succinate - + - -     
 
Key: +, positive correlations at one time-point; ++ positive correlations for at least two time-points; -, 
negative correlations at one time-point; --; negative correlation for at least two time-points; +/-, 
direction of correlation alternating between different time-points; *, tentative assignment; 3.22(m), 
multiplet spectral peak at δ 3.22; 3-HB, 3-hydroxybutyrate; Actino, Actinobacteria; Alpha, 
Alphaproteobacteria; Bacil, Bacilli; Bacter, Bacteroidia; Beta, Betaproteobacteria; Clos, Clostridia; 
DMA; dimethylamine; Erysi, Erysipelotrichia; Gamma, Gammaproteobacteria; GPC, 
glycerophoshocholine; (m), unassigned multiplet (accompanied by chemical shift region); PAG, 
phenylacetylglycine; s-, scyllo. 
 
Table 3. Immune–microbial correlates across the self-healing and non-healing infection models 
Microbial Class 
Infected BALB/c Infected C57BL/6 
IL-10 IL-12 IL-1ȕ CXCL
1 
IL-10 IL-12 IL-1ȕ CXCL
1 
Clostridia + ++ 
   
+ ++ 
 
Gammaproteobacteria 
  
+/- + + 
 
+ + 
Erysipelotrichia 
 
+ 
 
++ + + + 
 
Alphaproteobacteria ++ + 
   
+ ++ 
 
Betaproteobacteria +/- 
    
+ ++ 
 
Bacilli 
 
+ + 
 
+ + + 
 
Actinobacteria ++ + 
  
++ 
 
+ 
 
Bacteroidia ++ + 
  
+ + + 
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Key: +, positive correlations at one time-point; ++ positive correlations for at least two time-points; 
+/-, direction of correlation alternating between different time-points. 
  
44 
 
ABSTRACT GRAPHIC 
 
 
